Severe Neurological Ailments Reported in COVID-19 Patients

A survey of hospitalized patients finds some suffer fatigue, ischemic stroke, delirium, and other symptoms.

Written byLisa Winter
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, PATRIKSLEZAK

Although respiratory distress is the predominant complication of COVID-19, there are also rare, yet serious, neurological ailments that may arise. A survey of UK hospitals found that some patients also experience strokes, dementia-like symptoms, and delirium. The findings were published on June 25 in The Lancet Psychiatry.

Throughout April, neurologists in the United Kingdom used databases to find 125 hospitalized patients who tested positive for COVID-19 and also experienced certain neurological afflictions. More than half of the patients suffered a cerebrovascular event, with 57 patients enduring an ischemic stroke, while nine had an intracerebral hemorrhage.

“These relatively rare but incredibly severe complications get missed, like needles in a haystack,” Benedict Michael, a neurologist at the University of Liverpool and senior author of the paper, tells Science News. “Now that we know the rough idea of the scale of this, we desperately need research that gets to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies